Cambridge Investment Research Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $305K | Buy |
+3,101
| New | +$305K | ﹤0.01% | 2962 |
|
|
2022
Q4 | – | Sell |
-2,944
| Closed | -$285K | – | 3106 |
|
|
2022
Q3 | $285K | Sell |
2,944
-476
| -14% | -$46.1K | ﹤0.01% | 2399 |
|
|
2022
Q2 | $360K | Sell |
3,420
-5
| -0.1% | -$526 | ﹤0.01% | 2215 |
|
|
2022
Q1 | $590K | Buy |
3,425
+620
| +22% | +$107K | ﹤0.01% | 1969 |
|
|
2021
Q4 | $454K | Buy |
2,805
+262
| +10% | +$42.4K | ﹤0.01% | 2183 |
|
|
2021
Q3 | $379K | Buy |
2,543
+115
| +5% | +$17.1K | ﹤0.01% | 2264 |
|
|
2021
Q2 | $595K | Sell |
2,428
-780
| -24% | -$191K | ﹤0.01% | 1919 |
|
|
2021
Q1 | $849K | Buy |
3,208
+547
| +21% | +$145K | ﹤0.01% | 1543 |
|
|
2020
Q4 | $781K | Buy |
2,661
+26
| +1% | +$7.63K | ﹤0.01% | 1468 |
|
|
2020
Q3 | $623K | Buy |
2,635
+1,021
| +63% | +$241K | ﹤0.01% | 1461 |
|
|
2020
Q2 | $320K | Buy |
1,614
+35
| +2% | +$6.94K | ﹤0.01% | 1840 |
|
|
2020
Q1 | $290K | Sell |
1,579
-97
| -6% | -$17.8K | ﹤0.01% | 1700 |
|
|
2019
Q4 | $280K | Buy |
+1,676
| New | +$280K | ﹤0.01% | 1953 |
|
|
2019
Q1 | – | Sell |
-8,712
| Closed | -$1.02M | – | 2279 |
|
|
2018
Q4 | $1.02M | Buy |
8,712
+48
| +0.6% | +$5.62K | 0.01% | 924 |
|
|
2018
Q3 | $1.08M | Sell |
8,664
-5,468
| -39% | -$684K | 0.01% | 980 |
|
|
2018
Q2 | $1.21M | Buy |
14,132
+783
| +6% | +$66.9K | 0.01% | 883 |
|
|
2018
Q1 | $805K | Buy |
+13,349
| New | +$805K | 0.01% | 1057 |
|
|
2017
Q3 | – | Sell |
-10,735
| Closed | -$674K | – | 1998 |
|
|
2017
Q2 | $674K | Buy |
+10,735
| New | +$674K | 0.01% | 1024 |
|